~~<i id='EF9ECFF58C'><strike id='EF9ECFF58C'><tt id='EF9ECFF58C'><pre id='EF9ECFF58C'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：hotspot 2025-09-27 21:55:51 - browse：376

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： BridgeBio heart drug succeeds in pivotal study

hotspot

focus

hotspot

knowledge

hotspot

StemcellsSpencerPlatt/GettyImagesFederalofficialsmovedonWednesdaytostoptwoclinicsfromcontinuingtooff

WSS

Readout LOUD podcast: How biotech is using artificial intelligence

How digital tools helped lower hypertension in marginalized patients

Private equity deals in Medicare Advantage declines

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

A look at other Americans who have crossed into North Korea over the years

BioAge raises $170M for combination therapy with Zepbound

Wikipedia

hotspot

hotspot

Hollywood unions extend contract negotiations for actors

What we know about the American soldier detained in North Korea

Walensky prepares to leave CDC — and Congress — behind

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

New air purifier tech could be key to improving indoor air quality

Biden report: The neurospychology of memory and aging

Hollywood unions extend contract negotiations for actors

Vivek Ramaswamy, who's embraced Trump on the campaign trail, condemned him after Jan. 6

focus

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Biden report: The neurospychology of memory and aging

For Medicare Advantage, Democrats want stronger protections around AI

A strong 6.5

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Study: Hearing aids may slow cognitive decline in those at risk

hotspot

hotspot

knowledge

hotspot